Strategy for Mismatched Stem Cell Transplants Triggers Protection Against Graft-vs.-Host
October 7, 2009 (Research Reports) - A new technique being tested in stem-cell transplants from imperfectly matched donors has revealed a striking, unforeseen response that can suppress graft-versus-host disease, a common and dangerous complication of mismatched transplants, report scientists from Dana-Farber Cancer Institute. The research was funded by grants from the National Institutes of Health, The Leukemia & Lymphoma Society, and the American Society of Blood and Marrow Transplantation. Read more.
The Leukemia & Lymphoma SocietyŽ (LLS) is the world's largest voluntary health
agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma,
Hodgkin's disease and myeloma, and improve the quality of life of patients
and their families. LLS funds lifesaving blood cancer research around the
world and provides free information and support services.
Need Help? Contact us by email,
mail,
or call (800) 955-4572
print page
email this page
